Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.

Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA.

Neuroscience. 1995 Oct;68(3):955-62.

PMID:
8577387
2.
3.
4.

[3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum.

Masuo Y, Pélaprat D, Scherman D, Rostène W.

Neurosci Lett. 1990 Jun 22;114(1):45-50.

PMID:
1974339
5.

In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.

Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR.

J Med Chem. 1996 Jan 5;39(1):191-6.

PMID:
8568807
6.

Autoradiographic distribution of the eye monoaminergic synaptic vesicles.

Denis P, Nordmann JP, Scherman D, Saraux H, Rostène W.

Ophthalmic Res. 1994;26(4):232-9.

PMID:
7808734
7.

Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.

Zucker M, Weizman A, Rehavi M.

Life Sci. 2001 Sep 28;69(19):2311-7.

PMID:
11669473
8.

Induction of the vesicular monoamine transporter by elevated potassium concentration in cultures of rat sympathetic neurons.

Desnos C, Raynaud B, Vidal S, Weber MJ, Scherman D.

Brain Res Dev Brain Res. 1990 Mar 1;52(1-2):161-6.

PMID:
2331784
9.

Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole.

Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA.

Exp Neurol. 2003 Sep;183(1):81-6.

PMID:
12957491
10.

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K.

Eur J Pharmacol. 1995 Dec 29;294(2-3):577-83.

PMID:
8750721
12.
13.

[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain.

Scherman D, Raisman R, Ploska A, Agid Y.

J Neurochem. 1988 Apr;50(4):1131-6.

PMID:
3346671
14.

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.

Speciale SG, Liang CL, Sonsalla PK, Edwards RH, German DC.

Neuroscience. 1998 Jun;84(4):1177-85.

PMID:
9578404
15.
17.

Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.

Rehavi M, Goldin M, Roz N, Weizman A.

Brain Res Mol Brain Res. 1998 Jun 1;57(1):31-7.

PMID:
9630494
18.

Binding of 125I-iodovinyltetrabenazine to CNS vesicular monoamine transport sites.

Kung MP, Canney DJ, Frederick D, Zhuang Z, Billings JJ, Kung HF.

Synapse. 1994 Nov;18(3):225-32.

PMID:
7855735
19.

Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.

Araki T, Tanji H, Kato H, Mizugaki M, Itoyama Y.

Eur J Pharm Sci. 1999 Aug;8(4):261-7.

PMID:
10425376
20.

In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.

Kilbourn MR, Sherman PS, Kuszpit K.

Synapse. 2002 Mar 1;43(3):188-94.

PMID:
11793424
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk